Covalon Technologies Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

Covalon Technologies şirketinin temettü ödeme geçmişi bulunmamaktadır.

Anahtar bilgiler

n/a

Temettü verimi

Geri Alım Getirisi

Toplam Hissedar Getirisi	0%
Gelecekteki Temettü Verimi	n/a
Temettü Büyümesi	n/a
Bir sonraki temettü ödeme tarihi	n/a
Eski temettü tarihi	n/a
Hisse başına temettü	n/a
Ödeme oranı	n/a

Son temettü ve geri alım güncellemeleri

Güncelleme yok

Recent updates

Covalon Technologies Ltd.'s (CVE:COV) 25% Share Price Surge Not Quite Adding Up

Aug 18

We Think Covalon Technologies (CVE:COV) Can Afford To Drive Business Growth

Aug 10

Optimistic Investors Push Covalon Technologies Ltd. (CVE:COV) Shares Up 83% But Growth Is Lacking

Jun 16

Covalon Technologies (CVE:COV) Is In A Good Position To Deliver On Growth Plans

May 01

Covalon Technologies Ltd.'s (CVE:COV) Price Is Right But Growth Is Lacking After Shares Rocket 25%

Feb 17

Insufficient Growth At Covalon Technologies Ltd. (CVE:COV) Hampers Share Price

Dec 22

We Think Covalon Technologies (CVE:COV) Can Afford To Drive Business Growth

Sep 02

We Think Covalon Technologies (CVE:COV) Needs To Drive Business Growth Carefully

May 26

Is Covalon Technologies (CVE:COV) Using Too Much Debt?

Apr 29

Covalon Technologies (CVE:COV) Is Making Moderate Use Of Debt

Dec 29

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: COV şirketinin hisse başına düşen temettülerinin geçmişte istikrarlı olup olmadığını belirlemek için yeterli veri yok.

Büyüyen Temettü: COV şirketinin temettü ödemelerinin artıp artmadığını belirlemek için yeterli veri yok.

Piyasaya Karşı Temettü Getirisi

Covalon Technologies Piyasaya Karşı Temettü Getirisi

COV temettü verimi piyasa ile karşılaştırıldığında nasıldır?
Segment	Temettü Verimi
Şirket (COV)	n/a
Pazarın Alt %25'i (CA)	1.7%
Pazarın En İyi %25'i (CA)	6.2%
Sektör Ortalaması (Biotechs)	2.1%
Analist tahmini (COV) (3 yıla kadar)	n/a

Önemli Temettü: COV şirketinin temettü getirisi, şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, temettü ödeyenlerin en alttaki %25'lik dilimine göre değerlendirilemiyor.

Yüksek Temettü: Şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, COV şirketinin temettü getirisi, temettü ödeyenlerin en üst %25'ine göre değerlendirilemiyor.

Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: COV şirketinin temettü ödemelerinin kazançlarla karşılanıp karşılanmadığını belirlemek için ödeme oranını hesaplamak üzere yeterli veri yok.

Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: COV herhangi bir ödeme bildirmediğinden temettülerin sürdürülebilirliği hesaplanamıyor.

Covalon Technologies Temettüler ve Geri Alımlar

Temettü kriter kontrolleri 0/6

Anahtar bilgiler

Son temettü ve geri alım güncellemeleri

Recent updates

New minor risk - Shareholder dilution

Third quarter 2024 earnings released: EPS: CA$0.06 (vs CA$0.02 loss in 3Q 2023)

Covalon Technologies Ltd.'s (CVE:COV) 25% Share Price Surge Not Quite Adding Up

Covalon Technologies Ltd. to Report Q3, 2024 Results on Aug 21, 2024

We Think Covalon Technologies (CVE:COV) Can Afford To Drive Business Growth

Optimistic Investors Push Covalon Technologies Ltd. (CVE:COV) Shares Up 83% But Growth Is Lacking

Second quarter 2024 earnings released: EPS: CA$0.06 (vs CA$0.028 loss in 2Q 2023)

Covalon Technologies Ltd. to Report Q2, 2024 Results on May 29, 2024

Covalon Technologies (CVE:COV) Is In A Good Position To Deliver On Growth Plans

First quarter 2024 earnings released: CA$0.03 loss per share (vs CA$0.015 loss in 1Q 2023)

Covalon Technologies Ltd.'s (CVE:COV) Price Is Right But Growth Is Lacking After Shares Rocket 25%

Full year 2023 earnings released: CA$0.18 loss per share (vs CA$0.36 loss in FY 2022)

Covalon Technologies Ltd. Announces Appointment of Kim Crooks as Senior Vice President - Operations

Insufficient Growth At Covalon Technologies Ltd. (CVE:COV) Hampers Share Price

Covalon Technologies Ltd., Annual General Meeting, Mar 06, 2024

Covalon Technologies Ltd. to Showcase Innovative Solutions at the Prestigious ANCC National Magnet Conference in Chicago

Covalon Technologies Ltd. Announces Chief Executive Officer Changes

Covalon Technologies Ltd. Appoints Joseph Cordiano as Independent Director

We Think Covalon Technologies (CVE:COV) Can Afford To Drive Business Growth

Third quarter 2023 earnings released: CA$0.02 loss per share (vs CA$0.062 loss in 3Q 2022)

Covalon Technologies Ltd. to Report Q3, 2023 Results on Aug 16, 2023

Less than half of directors are independent

Less than half of directors are independent

Second quarter 2023 earnings released: CA$0.03 loss per share (vs CA$0.095 loss in 2Q 2022)

We Think Covalon Technologies (CVE:COV) Needs To Drive Business Growth Carefully

Covalon Technologies Ltd. to Report Q2, 2023 Results on May 25, 2023

First quarter 2023 earnings released: CA$0.02 loss per share (vs CA$0.043 loss in 1Q 2022)

Covalon Technologies Ltd. to Report Q1, 2023 Results on Feb 23, 2023

Full year 2022 earnings released: CA$0.36 loss per share (vs CA$0.016 profit in FY 2021)

Covalon Technologies Ltd. to Report Q4, 2022 Results on Jan 25, 2023

Covalon Technologies Ltd., Annual General Meeting, Mar 08, 2023

Covalon Technologies Ltd. Announces Its Newest Advanced Wound Care Product, ColActive Plus Powder

Covalon Technologies Ltd. to Showcase Infection Prevention Solutions at the Association for Vascular Access Annual Scientific Meeting

Covalon Technologies Ltd. to Introduce New Infection Prevention Products at the Annual Association of Pediatric Hematology/Oncology Nurses Conference

Third quarter 2022 earnings released: CA$0.06 loss per share (vs CA$0.041 profit in 3Q 2021)

Covalon Technologies Ltd. to Report Q3, 2022 Results on Aug 29, 2022

Second quarter 2022 earnings released: CA$0.095 loss per share (vs CA$0.011 loss in 2Q 2021)

Covalon Technologies Ltd. to Report Q2, 2022 Results on May 30, 2022

Covalon Technologies Ltd. Appoints Mark Doolittle as Senior Vice President, Commercial Sales

Covalon Technologies Ltd. Appoints Ron Hebert as Senior Vice President of Marketing

Covalon Technologies Ltd. to Report Q1, 2022 Results on Mar 01, 2022

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Independent Director Myrna Francis has left the company

Independent Director Myrna Francis has left the company

Independent Chairman of the Board recently bought CA$103k worth of stock

Third quarter 2021 earnings released: EPS CA$0.041 (vs CA$0.012 in 3Q 2020)

Covalon Technologies Undertakes A Strategic Review Process

Second quarter 2021 earnings released

Is Covalon Technologies (CVE:COV) Using Too Much Debt?

First quarter 2021 earnings released: CA$0.01 loss per share (vs CA$0.045 loss in 1Q 2020)

Covalon Technologies Ltd. to Report Q1, 2021 Results on Mar 01, 2021

New 90-day high: CA$1.75

Full year 2020 earnings released: CA$0.27 loss per share (vs CA$0.41 loss in FY 2019)

New 90-day high: CA$1.36

Covalon Technologies (CVE:COV) Is Making Moderate Use Of Debt

Covalon Technologies Ltd. Appoints Amir Boloor as Chair of the Company's Board of Directors

Earnings released

Covalon Technologies Ltd. to Report Q3, 2020 Results on Aug 24, 2020

New 90-day low - CA$1.07

Ödemelerde İstikrar ve Büyüme

Piyasaya Karşı Temettü Getirisi

Hissedarlara Ödenen Kazanç

Hissedarlara Nakit Ödeme

Güçlü temettü ödeyen şirketleri keşfedin